Indivior Pharmaceuticals Inc
INDV
Rang in Aktien
#3885
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Aktienkurs
$34.01
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$4.24B
Veränderung (1 Tag)
4.81%
Veränderung (1 Jahr)
40.02%
Land
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategorie
Healthcare
P/B-Verhältnis für Indivior Pharmaceuticals Inc (INDV)
P/B-Verhältnis zum October 2026 TTM: -20.59
Laut den neuesten Finanzberichten und dem Aktienkurs von Indivior Pharmaceuticals Inc beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) -20.59. Am Ende des Jahres 2023 lag das P/B-Verhältnis bei 31.28.
P/B-Verlauf für Indivior Pharmaceuticals Inc von 2016 bis 2026
P/B-Verhältnis zum Jahresende
| Jahr | P/B-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/B-Verhältnis | P/B-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
